Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Manufacturer Education Grants To Purchasers May Be Kickback, IG Says

Executive Summary

Education and research grants to purchasers from pharmaceutical manufacturers may violate the anti-kickback statute, the HHS Inspector General's compliance guide contends

You may also be interested in...



Drug Promotion Ban At Annual Medical Meetings Urged By Public Citizen

Pharmaceutical promotional activities at professional society annual conventions should be banned, Public Citizen declares in a study published in the recent issue of the Journal of Public Health Policy

Drug Promotion Ban At Annual Medical Meetings Urged By Public Citizen

Pharmaceutical promotional activities at professional society annual conventions should be banned, Public Citizen declares in a study published in the recent issue of the Journal of Public Health Policy

Primary Care Rx Market Offers Second-Rate Return On Investment – Bristol

Pharmaceutical companies marketing primary care products are unlikely to see a significant return on their investment, Bristol-Myers Squibb CFO Andrew Bonfield declared June 10

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel